s novel, patent-pending device uses a unique approach to extract high yields of nucleic acids, proteins, lipids, and small molecules from tough, fibrous, and other difficult-to-disrupt samples, such as muscle, skin, plant cell walls, and insects, and with minimal damage to fragile molecules. We believe this product fills an existing customer need, and that utilizing our very effective worldwide distribution network, we can be highly successful in placing this product within our existing customer base. And since the PCT Shredder uses a similar processing container (PULSE Tube(C)) as used in PBI's PCT Sample Preparation System, successful placement of the PCT Shredder can lead not only to revenue for both companies, but also to increased visibility of PBI's PCT Sample Preparation System."
Mr. Jahn concluded: "PBI has publicly disclosed that they are actively seeking to raise additional capital through equity financing under terms consistent with shareholder approval obtained on September 25, 2008. We will be participating in this financing, as we believe that the technology is sound, the market is large, the future is very bright, and because we want to be an integral part of the new, refocused PBI.
Mr. Richard T. Schumacher, President, and CEO of PBI commented: "Omni has an extensive homogenization product line (including high throughput automated equipment) that has been recognized for years for its quality and dependability. They continually develop new and improved homogenization products to satisfy changing customer needs. They have also been very successful in marketing and distributing their products through effective distribution channels in every major market in the world. We are very pleased to have the opportunity to work with Karl and his team to aggressively distribute the PCT Shredder worldwide, and also to co-develop a new concept in laboratory-scale sample preparation that combines the advantages of both h
Page: 1 2 3 4 5 Related biology technology :1
|SOURCE Pressure BioSciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved
. NicOx Naproxcinod Shows Highly Significant Reduction in Daytime Blood Pressure Versus Naproxen2
. Volcano Corporation Announces Launch of PrimeWire(TM) Pressure Guidewire and s5-FFR Option for Existing Fleet of s5 IVUS Consoles3
. Radi Medical Systems AB and GE Healthcare Announce Cooperation to Integrate FFR and PressureWire(R) Aeris in GE Mac-Lab(R) IT4
. Pressure BioSciences, Inc. Provides Corporate Update5
. Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending PCT Shredder at the Meeting6
. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)7
. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies8
. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update9
. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update10
. Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics11
. Healthcare Industry Faces Mounting Pressure to Prevent On-The-Job Violence, Says Veteran Safety and Health Attorney